Compare · DASH vs NH
DASH vs NH
Side-by-side comparison of DoorDash Inc. (DASH) and NantHealth Inc. (NH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DASH and NH operate in EDP Services (Technology), so they compete in similar markets.
- DASH is the larger of the two at $35.57B, about 400.1x NH ($88.9M).
- DASH has hit the wire 18 times in the past 4 weeks while NH has been quiet.
- DASH has more recent analyst coverage (25 ratings vs 0 for NH).
- Company
- DoorDash Inc.
- NantHealth Inc.
- Price
- $152.45-2.79%
- $1.96-32.41%
- Market cap
- $35.57B
- $88.9M
- 1M return
- -11.10%
- -
- 1Y return
- -29.91%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2016
- News (4w)
- 18
- 0
- Recent ratings
- 25
- 0
DoorDash Inc.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service; DoorDash Storefront that enables merchants to offer consumers on-demand access to e-commerce. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.
NantHealth Inc.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers GPS Cancer, a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing; Omics Core, an in-vitro diagnostic built on a custom-targeted whole exome sequencing platform; and Quadris, a data solution that includes multi-data analysis, reporting, and professional service. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Latest DASH
- Director Kovac Milan bought $6,237 worth of shares (40 units at $155.94), increasing direct ownership by 2% to 1,942 units (SEC Form 4)
- Director Tang Stanley acquired 23,125 shares as part of a pre-agreed trading plan and sold $3,646,189 worth of shares (23,125 units at $157.67) as part of a pre-agreed trading plan (SEC Form 4)
- DoorDash Ads Becomes a Global Commerce Media Platform
- CHIEF BUSINESS OFFICER Yandell Keith sold $410,576 worth of shares (2,643 units at $155.34) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 81,106 units (SEC Form 4)
- PRESIDENT AND COO Adarkar Prabir exercised 10,000 shares at a strike of $7.16 and sold $3,375,042 worth of shares (21,739 units at $155.25) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 959,076 units (SEC Form 4)
- DoorDash, Deliveroo and Wolt Debut First-Ever International Campaign Celebrating the FIFA World Cup 2026™
- Summer of DashPass Is Back to Help Fans Make the Most of FIFA World Cup 2026™
- DoorDash and Dollar Tree Partner to Bring Greater Value and Thrill of the Hunt Discovery On-Demand
- GENERAL COUNSEL AND SECRETARY Sherringham Tia sold $441,047 worth of shares (2,743 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 128,216 units (SEC Form 4)
- CHIEF ACCOUNTING OFFICER Lee Gordon S exercised 2,000 shares at a strike of $17.57 and sold $354,381 worth of shares (2,204 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 89,447 units (SEC Form 4)
Latest NH
- SEC Form 15-12G filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Leadership Update
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form EFFECT filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form POS AM filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- SEC Form S-8 POS filed by NantHealth Inc.
- NantHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits